2020
DOI: 10.3390/molecules25061291
|View full text |Cite
|
Sign up to set email alerts
|

Recent Bio-Advances in Metal-Organic Frameworks

Abstract: Metal-organic frameworks (MOFs) have found uses in adsorption, catalysis, gas storage and other industrial applications. Metal Biomolecule Frameworks (bioMOFs) represent an overlap between inorganic, material and medicinal sciences, utilising the porous frameworks for biologically relevant purposes. This review details advances in bioMOFs, looking at the synthesis, properties and applications of both bioinspired materials and MOFs used for bioapplications, such as drug delivery, imaging and catalysis, with a f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
27
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 54 publications
(30 citation statements)
references
References 127 publications
(172 reference statements)
0
27
0
3
Order By: Relevance
“…The"Radio-immuno Metal-Organic" (RiMO) compound RiMO-301 (Rimo Therapeutics Inc.) was the first therapeutic MOF compound administered to human patients in aPhase Iclinical trial. [42] Theintrinsically nontoxic RiMO-301 scaffold enhances the efficacyo fX -ray radiotherapy by serving as ar adio-sensitizing agent after intratumoral injection and irradiation. Shortly thereafter,two additional antitumoral nanoscale coordination polymers, CPI-100 and CPI-200 (Coordination Pharmaceuticals,I nc.…”
Section: Mof-based Clinical Trialsmentioning
confidence: 99%
See 2 more Smart Citations
“…The"Radio-immuno Metal-Organic" (RiMO) compound RiMO-301 (Rimo Therapeutics Inc.) was the first therapeutic MOF compound administered to human patients in aPhase Iclinical trial. [42] Theintrinsically nontoxic RiMO-301 scaffold enhances the efficacyo fX -ray radiotherapy by serving as ar adio-sensitizing agent after intratumoral injection and irradiation. Shortly thereafter,two additional antitumoral nanoscale coordination polymers, CPI-100 and CPI-200 (Coordination Pharmaceuticals,I nc.…”
Section: Mof-based Clinical Trialsmentioning
confidence: 99%
“…Specifically,t he phase Ic linical trial of aR iMO-301 radio-immunotherapy against advanced tumors in human patients has successfully been initiated as the first MOF-in-human clinical study. [42] Finally,t he application of MOF-based devices has revolutionized the area of water harvesting due to their superiority over alternative materials in arid climates. [43] This Review will focus on the impressive progress in harnessing the unique MOF and COF properties in various fields of application such as gas separation and storage,vapor adsorption, catalysis,c hemical sensing,b iomedical applications,a nd ionic conductors.W ew ish to spotlight the large application potential of these reticular materials by presenting the milestones that have propelled the research in this field into novel and unexpected realms of material chemistry.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Abgesehen von bedeutenden Fortschritten bei Gasspeicheranwendungen wurden auch Erfolge in der Medizin erzielt. Insbesondere wurde die Phase I der klinischen Studie für das Radioimmuntherapeutikum RiMO‐301 gegen fortgeschrittene Tumoren bei menschlichen Patienten erfolgreich eingeleitet – die erste klinische Studie mit MOFs am Menschen [42] . Und schließlich hat die Anwendung von MOF‐basierten Geräten den Bereich der Wassergewinnung aufgrund ihrer Überlegenheit gegenüber alternativen Materialien in trockenem Klima revolutioniert [43] …”
Section: Introductionunclassified
“…There are certain properties associated with MOFs, such as their versatile architecture, increased internal surface area, and ease of tuning their configuration by altering any of their components, i.e., either metal or organic ligand, that make them ideal candidates for applications in drug delivery systems, imaging, and sensors [ 10 ]. Therefore, the selection of components in MOFs should be such that it is environmentally and biologically compatible [ 11 ].…”
Section: Introductionmentioning
confidence: 99%